Louis C. Bock, Director, 10% Owner at Orexigen Therapeutics, Inc. (OREX), sold 1,499 shares at $15.38 ($23K) on 2007-11-15, disclosed to the SEC on 2007-11-16.
Open-market sale of $23k OREX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.38 | 100 | $2K | 6.6% |
| 2 | $15.56 | 100 | $2K | 6.7% |
| 3 | $15.60 | 1,299 | $20K | 86.8% |
| Total | $15.58 avg | 1,499 | $23K | 100% |
| Filing → |
| OREX | BUY | 2014-11-13 | $151K | — | Filing → |
| ZGNX | BUY | 2011-09-22 | $2.5M | — | Filing → |
| HZNP | BUY | 2011-08-04 | $2.8M | — | Filing → |